Patient Guide: A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 283 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06112379
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 283 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Daphne, Alabama
  • Prescott, Arizona
  • Jonesboro, Arkansas
  • • And 280 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily